{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "K",
                    "alt": "N",
                    "position": "27"
                },
                "variant_string_id": "parkin K27N"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a neurodegenerative disorder characterised by the loss of dopaminergic neurons from the substantia nigra, and the presence of Lewy bodies. Autosomal recessive juvenile Parkinsonism (AR - JP) is directly linked to mutations in the parkin gene. The study focuses on the role of Parkin's Ubl domain in the regulation of its E3 - ubiquitin ligase activity and how pathogenic mutations in this domain may disrupt this regulation.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to Parkin mutations and Parkinson's disease, specifically highlighting the role of Parkin in AR - JP.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro autoubiquitination assays, cell transfections and ubiquitination assays, protein stability assays, interaction assays, isothermal titration calorimetry, UIM and SH3 effector assays, NMR experiments, peptide arrays, and thioester discharge assays were used. These assays were designed to study the autoubiquitination activity of Parkin, the interaction between its domains, and the effect of mutations.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they are directly related to the function of Parkin (E3 - ubiquitin ligase) and how mutations may disrupt its normal regulation, which is relevant to the disease mechanism. For example, autoubiquitination assays help understand how pathogenic mutations in the Ubl domain affect Parkin's activity, which is related to the disease - causing process.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For in vitro autoubiquitination assays, the reaction protocol was adapted from a previous study. In all assays, there is no clear mention of using both normal/negative/wild - type and abnormal/positive/null controls together. There is also no clear statement about using multiple replicates for all experiments.",
                    "judgment": "No",
                    "reasoning": "Based on the information provided, it seems that the basic controls and replicates conditions are not met as per the requirements. There is no clear indication that both types of controls were used, and no clear statement about multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The in vitro autoubiquitination assay was adapted from a previous study (Matsuda et al, 2006). Other assays like cell transfections, protein stability assays, etc., are standard techniques in the field of protein biochemistry and molecular biology.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro autoubiquitination assay has been previously used (cited from Matsuda et al, 2006), and other assays are standard techniques in the relevant field, meeting one of the conditions for this sub - step.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the parkin K27N variant is considered PS3_supporting because while the disease mechanism is clearly defined and the assays are applicable to the disease pathogenesis, the specific assay instances do not meet the basic controls and replicates criteria. However, the in vitro autoubiquitination assay has been previously used, and other assays are standard in the field, which gives some support to the pathogenicity of the variant based on functional evidence."
        },
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "Q",
                    "position": "33"
                },
                "variant_string_id": "parkin R33Q"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a neurodegenerative disorder characterised by the loss of dopaminergic neurons from the substantia nigra, and the presence of Lewy bodies. Autosomal recessive juvenile Parkinsonism (AR - JP) is directly linked to mutations in the parkin gene. The study focuses on the role of Parkin's Ubl domain in the regulation of its E3 - ubiquitin ligase activity and how pathogenic mutations in this domain may disrupt this regulation.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to Parkin mutations and Parkinson's disease, specifically highlighting the role of Parkin in AR - JP.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro autoubiquitination assays, cell transfections and ubiquitination assays, protein stability assays, interaction assays, isothermal titration calorimetry, UIM and SH3 effector assays, NMR experiments, peptide arrays, and thioester discharge assays were used. These assays were designed to study the autoubiquitination activity of Parkin, the interaction between its domains, and the effect of mutations.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they are directly related to the function of Parkin (E3 - ubiquitin ligase) and how mutations may disrupt its normal regulation, which is relevant to the disease mechanism. For example, autoubiquitination assays help understand how pathogenic mutations in the Ubl domain affect Parkin's activity, which is related to the disease - causing process.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For in vitro autoubiquitination assays, the reaction protocol was adapted from a previous study. In all assays, there is no clear mention of using both normal/negative/wild - type and abnormal/positive/null controls together. There is also no clear statement about using multiple replicates for all experiments.",
                    "judgment": "No",
                    "reasoning": "Based on the information provided, it seems that the basic controls and replicates conditions are not met as per the requirements. There is no clear indication that both types of controls were used, and no clear statement about multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The in vitro autoubiquitination assay was adapted from a previous study (Matsuda et al, 2006). Other assays like cell transfections, protein stability assays, etc., are standard techniques in the field of protein biochemistry and molecular biology.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro autoubiquitination assay has been previously used (cited from Matsuda et al, 2006), and other assays are standard techniques in the relevant field, meeting one of the conditions for this sub - step.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the parkin R33Q variant is considered PS3_supporting because while the disease mechanism is clearly defined and the assays are applicable to the disease pathogenesis, the specific assay instances do not meet the basic controls and replicates criteria. However, the in vitro autoubiquitination assay has been previously used, and other assays are standard in the field, which gives some support to the pathogenicity of the variant based on functional evidence."
        },
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "P",
                    "position": "42"
                },
                "variant_string_id": "parkin R42P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a neurodegenerative disorder characterised by the loss of dopaminergic neurons from the substantia nigra, and the presence of Lewy bodies. Autosomal recessive juvenile Parkinsonism (AR - JP) is directly linked to mutations in the parkin gene. The study focuses on the role of Parkin's Ubl domain in the regulation of its E3 - ubiquitin ligase activity and how pathogenic mutations in this domain may disrupt this regulation.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to Parkin mutations and Parkinson's disease, specifically highlighting the role of Parkin in AR - JP.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro autoubiquitination assays, cell transfections and ubiquitination assays, protein stability assays, interaction assays, isothermal titration calorimetry, UIM and SH3 effector assays, NMR experiments, peptide arrays, and thioester discharge assays were used. These assays were designed to study the autoubiquitination activity of Parkin, the interaction between its domains, and the effect of mutations.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they are directly related to the function of Parkin (E3 - ubiquitin ligase) and how mutations may disrupt its normal regulation, which is relevant to the disease mechanism. For example, autoubiquitination assays help understand how pathogenic mutations in the Ubl domain affect Parkin's activity, which is related to the disease - causing process.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For in vitro autoubiquitination assays, the reaction protocol was adapted from a previous study. In all assays, there is no clear mention of using both normal/negative/wild - type and abnormal/positive/null controls together. There is also no clear statement about using multiple replicates for all experiments.",
                    "judgment": "No",
                    "reasoning": "Based on the information provided, it seems that the basic controls and replicates conditions are not met as per the requirements. There is no clear indication that both types of controls were used, and no clear statement about multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The in vitro autoubiquitination assay was adapted from a previous study (Matsuda et al, 2006). Other assays like cell transfections, protein stability assays, etc., are standard techniques in the field of protein biochemistry and molecular biology.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro autoubiquitination assay has been previously used (cited from Matsuda et al, 2006), and other assays are standard techniques in the relevant field, meeting one of the conditions for this sub - step.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the parkin R42P variant is considered PS3_supporting because while the disease mechanism is clearly defined and the assays are applicable to the disease pathogenesis, the specific assay instances do not meet the basic controls and replicates criteria. However, the in vitro autoubiquitination assay has been previously used, and other assays are standard in the field, which gives some support to the pathogenicity of the variant based on functional evidence."
        },
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "46"
                },
                "variant_string_id": "parkin A46P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a neurodegenerative disorder characterised by the loss of dopaminergic neurons from the substantia nigra, and the presence of Lewy bodies. Autosomal recessive juvenile Parkinsonism (AR - JP) is directly linked to mutations in the parkin gene. The study focuses on the role of Parkin's Ubl domain in the regulation of its E3 - ubiquitin ligase activity and how pathogenic mutations in this domain may disrupt this regulation.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to Parkin mutations and Parkinson's disease, specifically highlighting the role of Parkin in AR - JP.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro autoubiquitination assays, cell transfections and ubiquitination assays, protein stability assays, interaction assays, isothermal titration calorimetry, UIM and SH3 effector assays, NMR experiments, peptide arrays, and thioester discharge assays were used. These assays were designed to study the autoubiquitination activity of Parkin, the interaction between its domains, and the effect of mutations.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they are directly related to the function of Parkin (E3 - ubiquitin ligase) and how mutations may disrupt its normal regulation, which is relevant to the disease mechanism. For example, autoubiquitination assays help understand how pathogenic mutations in the Ubl domain affect Parkin's activity, which is related to the disease - causing process.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For in vitro autoubiquitination assays, the reaction protocol was adapted from a previous study. In all assays, there is no clear mention of using both normal/negative/wild - type and abnormal/positive/null controls together. There is also no clear statement about using multiple replicates for all experiments.",
                    "judgment": "No",
                    "reasoning": "Based on the information provided, it seems that the basic controls and replicates conditions are not met as per the requirements. There is no clear indication that both types of controls were used, and no clear statement about multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The in vitro autoubiquitination assay was adapted from a previous study (Matsuda et al, 2006). Other assays like cell transfections, protein stability assays, etc., are standard techniques in the field of protein biochemistry and molecular biology.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro autoubiquitination assay has been previously used (cited from Matsuda et al, 2006), and other assays are standard techniques in the relevant field, meeting one of the conditions for this sub - step.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the parkin A46P variant is considered PS3_supporting because while the disease mechanism is clearly defined and the assays are applicable to the disease pathogenesis, the specific assay instances do not meet the basic controls and replicates criteria. However, the in vitro autoubiquitination assay has been previously used, and other assays are standard in the field, which gives some support to the pathogenicity of the variant based on functional evidence."
        },
